About Samsrita Labs Ltd
Samsrita Labs is embarking on a pivotal strategic diversification, expanding beyond its traditional human healthcare services. In alignment with the proposed amendment to the Company’s Objects Clause, this deliberate pivot allows the Company to venture into high-growth sectors. Concurrently, our core operations remain deeply anchored in India’s pharmaceutical and biotechnology landscape, which provides a resilient foundation for multi-sector scale.
Founded
1996
CEO
K Krishnam Raju
Employees
5
HQ
Hyderabad, India
Finished Products
1sale
₹0.02CrRaw Materials
1Purchase of Stock in Trade
₹0.02CrAbout Samsrita Labs Ltd
Samsrita Labs is embarking on a pivotal strategic diversification, expanding beyond its traditional human healthcare services. In alignment with the proposed amendment to the Company’s Objects Clause, this deliberate pivot allows the Company to venture into high-growth sectors. Concurrently, our core operations remain deeply anchored in India’s pharmaceutical and biotechnology landscape, which provides a resilient foundation for multi-sector scale.
Founded:1996
CEO:K Krishnam Raju
Employees:5
HQ:Hyderabad, India
Finished Products
1sale
₹0.02CrRaw Materials
1Purchase of Stock in Trade
₹0.02CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹25
52W Low
₹10
Volume27.88K
Avg VolumeN/A
Beta-0.14
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-3.38x
Valuation
P/B Ratio
2.35x
Valuation
EPS
₹-3.59
Valuation
Dividend Yield
0.00%
Valuation
ROE
-69.43%
Profitability
ROCE
-64.75%
Profitability
Revenue by Segment
Contribution & growth by business line
Healthcare services which includesRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.14x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.